from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2616/-

LFCtreatmentdescriptionclass of inhibitor

-1.043

Amikacinug/mL Amikacintranslation

-1.729

Cap5-10ug/mL Capreomycintranslation

-2.794

Rox10-50 ug/mL Roxithromycintranslation

-0.902

SM2-5 ug/mL Streptomycintranslation

-1.736

Tet5-10 ug/mL Tetracyclinetranslation

0.526

Rif0.2-5ug/mL Rifampicintranscription

-0.889

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.758

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.020

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.528

CPZ10-50 ug/mL Chlorpromazinerespiration

0.256

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.165

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.537

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.817

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.067

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.392

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.580

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.634

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.228

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.898

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.430

KCN5-20 ug/mL Potassium cyaniderespiration

0.014

NaN30.2-2 mM Sodium aziderespiration

-0.196

Nigericin50 uM Nigericinrespiration

-0.295

TRC10-150 ug/mL Triclosanrespiration

0.414

TRZ10-25 ug/mL Thioridazinerespiration

0.249

Valinomycin0.5-10 uM Valinomycinrespiration

-0.152

ZnSO42 mM ZnSO4respiration

0.789

menadione6-10 ug/mL Menadionerespiration

0.392

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.174

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.003

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.423

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.066

NRP_1Non-replicating persistence stage 1dosRassociated

-0.321

Amp0.2mg/mL AmpicillincellWall

-0.428

Cephalexin20-100 ug/mL CephalexincellWall

-0.233

Cerulenin0.32-5 ug/mL CerulenincellWall

0.098

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.159

EMB10-20 ug/mL EthambutolcellWall

0.321

Eta12-40 ug/mL EthionamidecellWall

0.301

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.173

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.210

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.314

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.979

BZA0.12 mg/mL BenzamidearomaticAmides

-0.248

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.017

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.288

H2O24 mM hydrogen peroxideDNAdamaging

0.045

Levo10 ug/mL LevofloxacinDNAdamaging

-0.303

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.260

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.234

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.179

UVUV-irradiationDNAdamaging

2.299

ARP41-4 ug/mL Antitubercular compound ARP4?

0.304

Antimycin12.5-50 ug/mL Antimycin A?

-0.033

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.254

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.323

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.184

PA8240.2-2 ug/mL PA-824?

0.339

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.081

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.093

Verapamil50 uM Verapamil?

-0.231

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.468

methoxatin10-20 ug/mL Methoxatin?